SEOUL, South Korea: Osstem Implant has expanded its global presence from an initial network of 12 overseas subsidiaries established in 2006 to 33 entities across 29 countries. Over the past two decades, the company has built a solid foundation for sustainable growth in international markets by leveraging its strengths in research and development (R & D), offering a structured clinical education system and employing a direct-sales business model. Osstem Implant plans to further accelerate its overseas market development as part of its strategy to strengthen its position in the global implant market.